Medtech startup Cosm Medical has secured $4.7 million CAD ($3.8 million USD) in an oversubscribed seed round to create custom medical devices for women suffering from pelvic floor disorders.
The new funds will enable Cosm to further develop and launch its digital gynecology platform and gynecological prosthetics, which it calls Gynethotics. The investment will also go toward expanding research and development, and operations. Cosm plans to double its team of 10 employees.
The startup combines novel physiological biomarkers, AI-driven cloud software, and 3D printing to create its custom prosthetics.
Fusion Fund led the round with participation from iGan Partners, MaRS IAF, Telus Pollinator Fund, Archangel Fund, and several physicians and angel investors. The round closed in late March and not all investors were disclosed.
Cosm Medical presented at the 2022 OBIO Investment Summit.